Generate a tailored SOP for Dr. Robert Damoiseaux. Improve your application with a focused, well-structured draft.
Robert Damoiseaux is a renowned professor and expert in High Throughput Screening (HTS) within the Department of Molecular and Medical Pharmacology of the David Geffen School of Medicine at UCLA. His research interests are centered on developing novel technologies for HTS in drug discovery and development. He directs the Molecular Screening Shared Resource (MSSR), a cutting-edge facility that collaborates on various research initiatives across UCLA, Caltech, and within the biotech and pharmaceutical industries. Damoiseaux obtained his Ph.D. in Bio-organic Chemistry from the University of Lausanne, where he worked under Dr. Kai Johnsson, the current Director of the Max Planck Institute for Medical Research in Munich. He previously held key roles at the Institute of Functional Genomics (GNF, Novartis), contributing significantly to the development of assay platforms for proteases. His extensive publication record includes over 100 manuscripts and patents focusing on high throughput screening and synthesis. Damoiseaux is recognized as a leading author for Wiley's 'Development of Therapeutic Agents Handbook' and serves as an editor for Springer’s 'Current Protocols in Molecular Biology.' He is also a member of an NIH study section special emphasis panel that reviews grants related to high throughput screening.
UCLA • Los Angeles, CA
Professor in Molecular Medical Pharmacology.
Molecular Screening Shared Resource • UCLA
Director of the cutting-edge facility involved in research projects.
UCLA • Los Angeles, CA
Associate Professor in Molecular Medical Pharmacology.
Molecular Screening Shared Resource • UCLA
Scientific Director for a shared resource center.
Ciphergen Biosystems Inc. • USA
Field Research Scientist role focused on innovations in biosystems.
Novartis Institute of Functional Genomics • USA
Fellow working on genomic studies.
Department of Economics admits primarily for the PhD program.